The Potential Role of Intrinsic Hypoxia Markers as Prognostic Variables in Cancer
- 1 August 2007
- journal article
- review article
- Published by Mary Ann Liebert Inc in Antioxidants and Redox Signaling
- Vol. 9 (8) , 1237-1294
- https://doi.org/10.1089/ars.2007.1623
Abstract
Tumor hypoxia is related to tumor progression and therapy resistance, which leads to poor patient outcome. It has been suggested that measuring the hypoxic status of a tumor helps to predict patient outcome and to select more targeted treatment. However, current methods using needle electrodes or exogenous markers have limitations due to their invasiveness or necessity for preinjection. Recent studies showed that hypoxia-regulated genes could be alternatively used as endogenous hypoxia markers. This is a review of 15 hypoxia-regulated genes, including hypoxia-inducible factor-1 and its targets, and their correlation with tumor hypoxia and patient outcome from 213 studies. Though most of the studies showed significance of these genes in predicting prognosis, there was no definitive prognostic and hypoxia marker. In conclusion, this review suggests the need for further studies with standardized methods to examine gene expression, as well as the use of multiple gene expressions.Keywords
This publication has 290 references indexed in Scilit:
- Serial Plasma Osteopontin Levels Have Prognostic Value in Metastatic Breast CancerClinical Cancer Research, 2006
- Vascular endothelial growth factor-A and Poly(A) binding protein-interacting protein 2 expression in human head and neck carcinomas: correlation and prognostic significanceBritish Journal of Cancer, 2006
- NF-κB inhibition: A double-edged sword in cancer?European Journal Of Cancer, 2006
- Gene Expression Programs in Response to Hypoxia: Cell Type Specificity and Prognostic Significance in Human CancersPLoS Medicine, 2006
- Prognostic significance of osteopontin expression in human prostate cancerInternational Journal of Cancer, 2005
- Prognostic relevance of TGF‐β1 and PAI‐1 in cervical cancerInternational Journal of Cancer, 2004
- Plasma osteopontinCancer, 2002
- AP-1 in cell proliferation and survivalOncogene, 2001
- Patterns and Emerging Mechanisms of the Angiogenic Switch during TumorigenesisPublished by Elsevier ,1996
- Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivoNature, 1993